incretin mimetic agents glp 1 receptor agonists Introduction to Diabetes Type and Type 2 GLP-1-based therapies for type 2

In contrast, the difference in liver fibrosis resolution stage did not reach statistical significance (liver fibrosis staging improved in 43% of participants in the semaglutide arm vs 33% in the placebo arm), potentially owing to a lack of power within the study or the relatively short follow-up time of 72 weeks

However, current research suggests that daily doses of up to 4 grams are generally safe, even in conjunction with antiplatelet or anticoagulant therapies (82)

doi: 10.1039/d2fo02842e 120

At this point, for research purposes, it should not be used

While our bodies naturally produce glutathione, factors such as stress, poor diet, aging, and environmental toxins can deplete its levels, leading to fatigue, inflammation, and weakened immunity